High-dose versus intermediate-dose cytarabine combined with mitoxantrone for the treatment of relapsed and refractory acute myeloid leukemia: Results of an age-adjusted randomized comparison

Hiddemann, W., Aul, C., Maschmeyer, G., Schönrock-Nabulsi, R., Ludwig, W. D., Bartholomäus, A., … Büchner, T. (1991). High-dose versus intermediate-dose cytarabine combined with mitoxantrone for the treatment of relapsed and refractory acute myeloid leukemia: Results of an age-adjusted randomized comparison. Seminars in Hematology, 28(3 SUPPL. 4), 35–38. https://doi.org/10.1007/978-3-642-76591-9_67